Innovator IBD ETF Leaders ETF
LDRS
LDRS was delisted on the 13th of August, 2021.
18 hedge funds and large institutions have $7.18M invested in Innovator IBD ETF Leaders ETF in 2018 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 6 closing their positions.
125% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 4
22% less funds holding
Funds holding: 23 → 18 (-5)
25% less capital invested
Capital invested by funds: $9.53M → $7.18M (-$2.34M)
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$675K |
| 2 |
Jane Street
New York
|
+$357K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$244K |
| 4 |
Koshinski Asset Management
Decatur,
Illinois
|
+$229K |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$127K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAIM
Financial Advocates Investment Management
Olympia,
Washington
|
-$2.65M |
| 2 |
VF
Virtu Financial
New York
|
-$1.02M |
| 3 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
-$234K |
| 4 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$223K |
| 5 |
GWM
Geneos Wealth Management
Englewood,
Colorado
|
-$51K |
LDRS Hedge Fund Activity: Q3 2018 in Review
18 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Innovator IBD ETF Leaders ETF (LDRS) for Q3 2018, worth a combined $7.18M — down 25% from $9.53M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of LDRS and 1 opened new positions — a net loss of 5 holders — while 4 trimmed existing stakes and 9 added.
The largest buyer was Susquehanna International Group, adding an estimated $675K. The largest seller was Financial Advocates Investment Management, exiting entirely with an estimated $2.65M sold.
- 18 institutional investors held Innovator IBD ETF Leaders ETF (LDRS) as of Q3 2018, down from 23 in Q2 2018.
- Funds reported $7.18M of Innovator IBD ETF Leaders ETF stock for Q3 2018, down 25% quarter-over-quarter.
- 1 fund opened new Innovator IBD ETF Leaders ETF positions in Q3 2018 and 6 closed out, a net change of -5 holders.
- The largest Innovator IBD ETF Leaders ETF buyer in Q3 2018 was Susquehanna International Group, an estimated $675K added.
- The largest Innovator IBD ETF Leaders ETF seller in Q3 2018 was Financial Advocates Investment Management, an estimated $2.65M sold.
Based on aggregated 13F filings for Q3 2018.